194 Consoli, A
#Nephrology #Dialysis #Semaglutide #GLP1 #Diabetes #Cardiovascular #EASD2025 #PatientSafety #MedicalResearch To view or add a comment, sign in Ive always been deeply invested in orphan respiratory diseases, and remember the hope around pirfenidone in-licensing, a drug that slowed IPF decline
One thing I learned as a chronically ill woman who grew up as a fat little girl is that my existence constantly triggers other peoples trauma
We do not offer or advertise compounded GLP-1 medications as substitutes for commercially available drugs
Contributing factors include: reduced nutritional intake (proteins, essential amino acids, competition between amino acid transporters, vitamin insufficiency [riboflavin: GSSG reductase, nicotinic acid: NADPH, pyridoxine (B 6 ): SAMe pathway], mitochondrial dysfunction: ATP deficiency, down regulation SAMe synthase, oxidation of SAMe pathway enzymes, enhanced GSH utilization: conjugation reactions (toxins, drugs), and overwhelming oxidative challenge